Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-22

Clinical Trial Update: Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an adequate tuberculosis regimen in hospitalized HIV-infected patients with severe immune suppression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Tuberculosis, HIV-1-infection | Phase 3 | Status: COMPLETED